Latest News for e-Therapeutics Stock (OTC:ETXPF)

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

E-THERAPEUTICS PLC ORD by E-Therapeutics PLC

e-Therapeutics PLC

Citigroup analyst George Kurosawa maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Neutral and lowers the price target from $260 to $220.

News

Price Target

Analyst Ratings

MANH

Citigroup Maintains Neutral on Manhattan Associates, Lowers Price Target to $220

Whales with a lot of money to spend have taken a noticeably bearish stance on Salesforce.
Looking at options history for Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 47% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $295,628 and 13, calls, for a total amount of $888,921.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $410.0 for Salesforce, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Salesforce's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Salesforce's substantial trades, within a strike price spectrum from $200.0 to $410.0 over the preceding 30 days.
<h3>Salesforce Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713982580_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$18.15</td>
<td>$18.05</td>
<td>$18.15</td>
<td>$330.00</td>
<td>$168.7K</td>
<td style="text-align: right;">145</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$45.15</td>
<td>$44.0</td>
<td>$44.0</td>
<td>$300.00</td>
<td>$158.4K</td>
<td style="text-align: right;">397</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$67.35</td>
<td>$65.8</td>
<td>$66.5</td>
<td>$230.00</td>
<td>$133.0K</td>
<td style="text-align: right;">16</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$21.85</td>
<td>$21.65</td>
<td>$21.65</td>
<td>$300.00</td>
<td>$99.5K</td>
<td style="text-align: right;">146</td>
<td style="text-align: right;">64</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$70.95</td>
<td>$68.5</td>
<td>$69.0</td>
<td>$230.00</td>
<td>$69.0K</td>
<td style="text-align: right;">16</td>
<td style="text-align: right;">10</td>
</tr>
</tbody>
</table>

<h3>About Salesforce</h3>
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Following our analysis of the options activities associated with Salesforce, we pivot to a closer look at the company's own performance.
<h3>Where Is Salesforce Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 1,846,367, with CRM's price up by 0.26%, positioned at $277.41.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 35 days.</li>
</ul>
<h3>Professional Analyst Ratings for Salesforce</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $351.0.
<ul>
<li>An analyst from Stifel persists with their Buy rating on Salesforce, maintaining a target price of $350. </li>
<li>Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $350.</li>
<li>An analyst from Needham downgraded its action to Buy with a price target of $345. </li>
<li>Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Salesforce, targeting a price of $360. </li>
<li>In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $350. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Salesforce options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Looking At Salesforce's Recent Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MBLY, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Mobileye Global.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 44%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $161,832, and 6 are calls, for a total amount of $422,540.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $28.0 to $42.0 for Mobileye Global over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Mobileye Global options trades today is 690.43 with a total volume of 1,266.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Mobileye Global's big money trades within a strike price range of $28.0 to $42.0 over the last 30 days.
<h3>Mobileye Global 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713982574_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MBLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$2.45</td>
<td>$2.4</td>
<td>$2.4</td>
<td>$31.00</td>
<td>$180.0K</td>
<td>2.2K</td>
<td style="text-align: right;">813</td>
</tr>
<tr>
<td>MBLY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$6.9</td>
<td>$6.6</td>
<td>$6.74</td>
<td>$30.00</td>
<td>$120.5K</td>
<td>1.2K</td>
<td style="text-align: right;">179</td>
</tr>
<tr>
<td>MBLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$7.1</td>
<td>$6.9</td>
<td>$7.0</td>
<td>$38.00</td>
<td>$66.5K</td>
<td>35</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MBLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$11.2</td>
<td>$11.0</td>
<td>$11.0</td>
<td>$42.00</td>
<td>$61.6K</td>
<td>56</td>
<td style="text-align: right;">56</td>
</tr>
<tr>
<td>MBLY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$6.6</td>
<td>$6.4</td>
<td>$6.53</td>
<td>$29.00</td>
<td>$45.4K</td>
<td>210</td>
<td style="text-align: right;">66</td>
</tr>
</tbody>
</table>

<h3>About Mobileye Global</h3>
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. Mobileye is the Company's only reportable operating segment. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System &amp; Vehicles. It also provides data services to Expedite Maintenance Operations with AI-Powered Road Survey Technology.
Having examined the options trading patterns of Mobileye Global, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Mobileye Global Standing Right Now?</h3>
<ul>
<li>With a volume of 1,625,084, the price of MBLY is up 1.48% at $30.88. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 1 days.</li>
</ul>
<h3>Professional Analyst Ratings for Mobileye Global</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $39.5.
<ul>
<li>Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Mobileye Global, targeting a price of $38. </li>
<li>In a positive move, an analyst from Wolfe Research has upgraded their rating to Outperform and adjusted the price target to $41. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Mobileye Global options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

MBLY

Spotlight on Mobileye Global: Analyzing the Surge in Options Activity

Financial giants have made a conspicuous bullish move on Lyft. Our analysis of options history for Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) revealed 11 unusual trades.
Delving into the details, we found 63% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $164,232, and 7 were calls, valued at $1,166,313.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $14.0 and $27.0 for Lyft, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Lyft stands at 2059.73, with a total volume reaching 1,463.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Lyft, situated within the strike price corridor from $14.0 to $27.0, throughout the last 30 days.
<h3>Lyft Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713982569_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$2.2</td>
<td>$2.17</td>
<td>$2.2</td>
<td>$17.00</td>
<td>$770.0K</td>
<td>1.6K</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$2.76</td>
<td>$2.67</td>
<td>$2.67</td>
<td>$14.00</td>
<td>$114.0K</td>
<td>286</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/03/24</td>
<td>$0.56</td>
<td>$0.37</td>
<td>$0.37</td>
<td>$17.50</td>
<td>$108.6K</td>
<td>4.0K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>LYFT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$12.05</td>
<td>$11.95</td>
<td>$12.0</td>
<td>$27.00</td>
<td>$73.2K</td>
<td>0</td>
<td style="text-align: right;">3</td>
</tr>
<tr>
<td>LYFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$1.31</td>
<td>$1.28</td>
<td>$1.3</td>
<td>$17.00</td>
<td>$65.0K</td>
<td>2.2K</td>
<td style="text-align: right;">546</td>
</tr>
</tbody>
</table>

<h3>About Lyft</h3>
Lyft is the second-largest ride-sharing service provider in the us and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
<h3>Present Market Standing of Lyft</h3>
<ul>
<li>With a volume of 12,069,459, the price of LYFT is down -2.48% at $16.5. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 13 days.</li>
</ul>
<h3>What The Experts Say On Lyft</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $21.0.
<ul>
<li>An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Lyft, which currently sits at a price target of $18. </li>
<li>An analyst from Tigress Financial persists with their Buy rating on Lyft, maintaining a target price of $24. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lyft options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

LYFT

Lyft's Options: A Look at What the Big Money is Thinking

The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing &nbsp;Novo Nordisk&nbsp;A/S&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) &#8216;s pricing strategies, particularly those of its diabetes and obesity&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/03/37989566/how-much-does-it-cost-to-make-novo-nordisks-ozempic-shockingly-low-against-1-000-price-tag-study-" rel="noreferrer noopener">medications, Ozempic and Wegovy</a>.
Senator Bernie Sanders emphasized the necessity of reducing prices to ensure accessibility for consumers and sustainability for governments.
Senator Sanders penned a letter to Novo Nordisk&#8217;s CEO, Lars Fruergaard Jorgensen, demanding internal communications regarding the pricing discrepancies between the U.S. and other countries.&nbsp;
The committee questioned why Wegovy, containing the same compound as Ozempic, bears a higher price tag, the New York Times&nbsp;<a target="_blank" href="https://www.nytimes.com/2024/04/24/well/live/ozempic-cost-senate.html?searchResultPosition=1" rel="noreferrer noopener">noted</a>. A response has been requested by May 8.
Senator Sanders also intended to investigate&nbsp;Eli Lilly And Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), the manufacturer of rival medications, Mounjaro and Zepbound, to address industry-wide pricing concerns.&nbsp;
With obesity affecting nearly 42% of American adults and over 11 percent with diabetes, ensuring affordability poses a significant challenge.
A recent study by the Kaiser Family Foundation (KFF) revealed that approximately 3.6 million overweight or obese patients with heart conditions covered under the U.S. Medicare program may become eligible for&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/03/37984877/insurance-coverage-for-weight-loss-drugs-elevance-cvs-health-become-first-to-extend-coverage-to-n" rel="noreferrer noopener">coverage of Wegovy</a>.&nbsp;
The study highlights that the expanded coverage would affect Medicare beneficiaries and other insurers&#8217; coverage for individuals with heart conditions.&nbsp;
Currently,&nbsp;Medicare prescription drug plans (Part D) administered by private insurers do not cover drugs approved solely for obesity.&nbsp;
However, new guidance suggests that drugs approved for secondary use Medicare covers could be eligible.
Citing the KFF study, Reuters highlights that the approval could open up Wegovy to over a quarter of the 13.7 million Medicare beneficiaries diagnosed with heart disease and obesity.&nbsp;
Among these eligible patients, approximately 1.9 million also have diabetes, making them already eligible for Medicare coverage of other drugs like Novo&#8217;s Ozempic.
Although some Part D plans have announced plans to cover Wegovy this year, broader coverage may be anticipated by 2025.&nbsp;
The extent of the drug&#8217;s coverage and its impact on Medicare spending will depend on various factors. These include the number of Part D plans adding coverage, potential restrictions on use such as prior authorization, and negotiated prices paid by plans.
Despite major insurance plans covering these medications to varying extents, rising costs have led to coverage restrictions and termination, exacerbating accessibility issues.&nbsp;
Medicaid and Medicare coverage disparities further compound the problem.
Price Action:&nbsp;NVO shares are down 1.91% at $126.18&nbsp;at the last check Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

Biotech

Large Cap

Health Care

Legal

Movers

General

What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk

Citigroup analyst Patrick Donnelly maintains Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Buy and raises the price target from $280 to $290.

Citigroup Maintains Buy on Danaher, Raises Price Target to $290

Heineken NV&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/HEINY#OTC">HEINY</a>) clocked&nbsp;revenue&nbsp;<a target="_blank" href="https://www.heinekenholding.com/investors/media-releases/heineken-holding-nv-reports-2024-first-quarter-trading" rel="noreferrer noopener">growth&nbsp;</a>of 7.2% Y/Y in the first quarter of FY24 to 8.18 billion euros, driven by volume growth of 4.3% Y/Y and net revenue (beia) per hectolitre increase of&nbsp;4.9% Y/Y.
Beer volume increased 4.7% organically Y/Y on growth across all regions, a sequential improvement in the performance of the business, boosted by calendar and one-off effects.&nbsp;
Beer volume came ahead of the company-provided market expectations of 2.5%,&nbsp;reported&nbsp;WSJ.
In particular, the Americas and Europe regions benefitted from the earlier timing of Easter&nbsp;and&nbsp;the Africa &amp; Middle East.
Also, the&nbsp;Asia Pacific regions gained from a soft comparable base last year due to one-off effects in Vietnam and Nigeria.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/23/08/34039199/cheers-to-no-cheers-heineken-closes-russian-operations-takes-300m-loss" rel="noreferrer noopener">Cheers To No Cheers: Heineken Closes Russian Operations, Takes €300M&nbsp;Loss</a>
Outlook: The company continues to expect FY24 operating&nbsp;profit (beia) to grow organically by a low- to high-single-digit and net profit (beia) organic growth to be lower than the operating profit (beia) organic growth.
Price Action: HEINY shares were trading higher by 1.39% at $49.71 at the last check Wednesday.
Photo: Engin Akyurt from Pixabay

Earnings

Equities

Media

HEINY

Heineken's Cheers: A Round of 7.2% Revenue Growth in Q1

Citigroup analyst James Hardiman maintains Mattel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) with a Buy and raises the price target from $25 to $26.

Citigroup Maintains Buy on Mattel, Raises Price Target to $26

WIIM

Boeing shares are trading lower after Moody's downgraded the company's Senior Unsecured rating from Baa2 to Baa3.

Citigroup analyst Patrick Donnelly maintains Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) with a Neutral and raises the price target from $135 to $145.

Citigroup Maintains Neutral on Quest Diagnostics, Raises Price Target to $145

Citigroup analyst Jason Bazinet downgrades Liberty SiriusXM Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSXMA#NASDAQ">LSXMA</a>) from Buy to Neutral and lowers the price target from $35 to $28.

Downgrades

LSXMA

Citigroup Downgrades Liberty SiriusXM Gr to Neutral, Lowers Price Target to $28

Hawthorn Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWBK#NASDAQ">HWBK</a>) reported quarterly earnings of $0.63 per share. This is a 34.04 percent increase over earnings of $0.47 per share from the same period last year.

HWBK

Hawthorn Bancshares Q1 EPS $0.63 Up From $0.47 YoY

Citigroup analyst Jason Gursky maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Buy and raises the price target from $508 to $525.

Citigroup Maintains Buy on Lockheed Martin, Raises Price Target to $525

Argus Research analyst Kevin Heal maintains Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) with a Buy and raises the price target from $36 to $39.

Argus Research Maintains Buy on Citizens Financial Group, Raises Price Target to $39

Citigroup analyst Itay Michaeli maintains General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) with a Buy and raises the price target from $95 to $96.

Citigroup Maintains Buy on General Motors, Raises Price Target to $96

Trading Ideas

Moody's Anticipates That Boeing Will Issue New Debt To Fund Free Cash Flow Shortfalls; Says Expects Ongoing Weak Performance In Commercial Airplanes Will Constrain Boeing's Free Cash Flow Generation For 2024 And 2025; Outlook Captures Material Degree Of Execution Risk In Boeing's Plan To Restore Compliance & Higher Quality To Commercial Aircraft Assembly Ops

Argus Research analyst John Eade maintains GE Aero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) with a Buy and raises the price target from $170 to $180.

Argus Research Maintains Buy on GE Aero, Raises Price Target to $180

The Biden-Harris Administration has announced a new rule requiring airlines&nbsp;to&nbsp;<a target="_blank" href="https://www.transportation.gov/briefing-room/biden-harris-administration-announces-final-rule-requiring-automatic-refunds-airline" rel="noreferrer noopener">swiftly issue automatic cash refunds to passengers.&nbsp;</a>
The U.S. Department of Transportation (DOT) finalized a rule mandating airlines to provide refunds under specific circumstances, aiming&nbsp;to eliminate disparities in refund policies across carriers.
Previously, airlines set varying standards, complicating refund requests for passengers.
Refunds&nbsp;will now be guaranteed&nbsp;for flight cancellations, significant schedule alterations, and delayed baggage return.
Under the new rule, refunds will be automatic, issued promptly within defined timeframes, and provided in cash or original payment method.
Some of the conditions that entitle passengers with a refund include the following:
Departure or arrival time difference of more than three hours for domestic flights and more than six hours for international flights.
If the passenger&nbsp;is scheduled&nbsp;to depart from a different origination airport or arrive at a different destination airport.
Itinerary with more connection points than&nbsp;that of&nbsp;the original itinerary, downgrading a passenger to a lower class of service.
If a passenger with a disability&nbsp;is scheduled&nbsp;to travel on a substitute&nbsp;aircraft&nbsp;that results in one or more accessibility features needed by the passenger being unavailable.
The above rules aim to simplify the refund process, eliminating cumbersome procedures and default issuance of travel credits.
DOT intends to propose further regulations, including bans on family seating fees and mandates for passenger compensation during flight disruptions.
Additionally, initiatives to enhance wheelchair users&#8217; travel rights are underway.
Some of the&nbsp;major&nbsp;air carriers in the U.S. include&nbsp;American Airlines Group Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>),&nbsp;United Airlines Holdings Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>),&nbsp;Delta Air Lines Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), and&nbsp;Southwest Airlines Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>).
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Regulations

Airline Passenger Rights Elevated: Biden Administration Enforces Refund Rule

Citigroup analyst Keith Horowitz maintains Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a Buy and raises the price target from $42 to $45.

Citigroup Maintains Buy on Truist Finl, Raises Price Target to $45

Moody's Says Also Downgraded Boeing's Short-Term Rating From P-2 To P-3; Downgrades Reflect "Inadequate" Performance Of Boeing's Commercial Airplanes Segment; Says Boeing's Negative Outlook Incorporates View That Headwinds Buffeting Commercial Airplanes Will Now Persist At Least Through 2026